Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS research · 2026-01-21

Clinical Trial Update: Telitacicept in the Treatment of Pediatric IgA Vasculitis-Associated Nephritis

View source ↗

Summary

Telitacicept is being studied in a pediatric trial for IgA vasculitis-associated nephritis (IgAVN). The trial (NCT07354503) is not yet recruiting and is sponsor…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Telitacicept

Snippet

Sponsor: The Children's Hospital of Zhejiang University School of Medicine | Conditions: IgAVN, IgA Vasculitis | Status: NOT_YET_RECRUITING